GSK Nigeria has a surprise MD resignation, Mylan tells us about its expansion in Latin America, and we cover the rest of the week's pharma hires.
GlaxoSmithKline Consumer Nigeria Plc has announced the resignation of its MD Chidi Okoro and the hiring of interim replacement Justin Korteasa.
GSK media manager Kalpesh Joshi told In-PharmaTechnologist.com Okor’s departure was “his choice, not GSK’s,” adding “Chidi has worked in our Nigerian Consumer Healthcare business for nearly 7 years, culminating in becoming the MD of GSK Nigeria Plc for the past four years.
“The company is evolving and Chidi believes it is time for someone new to make their mark on this business. An interim director has been appointed while we search for the right person to lead the business.”
On the type of candidate the company is seeking as a permanent replacement, Joshi said GSK would not limit the search to local candidates:
“We will cast the net wide and look at internal and external candidates. It is possible that the new managing director will be Nigerian but we will assess all the candidates based on their skills and experience and appoint the most qualified candidate.”
Okoro was the first Nigerian managing director of GSK Consumer Nigeria. He will remain in the position until March 1.
The announcement was not linked to any future plans by GSK to increase manufacturing in the region, said Joshi.
Copyright - Unless otherwise stated all contents of this web site are © 2015 - William Reed Business Media SAS - All Rights Reserved - Full details for the use of materials on this site can be found in the Terms & Conditions
in-Pharmatechnologist.com takes a look at the People on the Move this week.
The WHO Executive Board prepares for a special Ebola meeting, CEO leaves troubled biotech, and senior staff...
Novartis's CEO becomes President of EFPIA, a new head of R&D for Genentech, and more People on...